Cargando…

Identification of potential biomarkers of inflammation-related genes for ischemic cardiomyopathy

OBJECTIVE: Inflammation plays an important role in the pathophysiology of ischemic cardiomyopathy (ICM). We aimed to identify potential biomarkers of inflammation-related genes for ICM and build a model based on the potential biomarkers for the diagnosis of ICM. MATERIALS AND METHODS: The microarray...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jianru, Xie, Shiyang, Cheng, Yanling, Li, Xiaohui, Chen, Jian, Zhu, Mingjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445158/ https://www.ncbi.nlm.nih.gov/pubmed/36082132 http://dx.doi.org/10.3389/fcvm.2022.972274

Ejemplares similares

Identification and validation of ferroptosis-related genes and immune infiltration in ischemic cardiomyopathy
por: Huang, Kai, et al.
Publicado: (2023)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Ferroptosis and Autophagy-Related Genes in the Pathogenesis of Ischemic Cardiomyopathy
por: Zheng, Yue, et al.
Publicado: (2022)

The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)

Bibliometric analysis of the inflammation in diabetic cardiomyopathy
por: Zhu, Ning, et al.
Publicado: (2022)

Transcriptome analysis reveals ADAMTS15 is a potential inflammation-related gene in remote ischemic postconditioning
por: Zuo, Bo, et al.
Publicado: (2023)

Social Inequalities in Non-ischemic Cardiomyopathies
por: Amiya, Eisuke
Publicado: (2022)

Inflammation in Metabolic Cardiomyopathy
por: Wenzl, Florian A., et al.
Publicado: (2021)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Influence and risk factors of postoperative infection after surgery for ischemic cardiomyopathy
por: Wen, Bing, et al.
Publicado: (2023)

Heat Shock Proteins: Potential Modulators and Candidate Biomarkers of Peripartum Cardiomyopathy
por: Chakafana, Graham, et al.
Publicado: (2021)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
por: Graber, Michael, et al.
Publicado: (2022)

Global burden of myocarditis and cardiomyopathy in children and prediction for 2035 based on the global burden of disease study 2019
por: Ba, Hongjun, et al.
Publicado: (2023)

Association of Serum Biomarkers and Cardiac Inflammation in Patients With Atrial Fibrillation: Identification by Positron Emission Tomography
por: Chen, Bi-Xi, et al.
Publicado: (2021)

Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke
por: Yu, Fang, et al.
Publicado: (2021)

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM)
por: Wang, Lin, et al.
Publicado: (2021)

Serum Biomarkers of Endothelial Dysfunction in Fabry Associated Cardiomyopathy
por: Loso, Jefferson, et al.
Publicado: (2018)

Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver?
por: Meraviglia, Viviana, et al.
Publicado: (2021)

Identification and Verification of Feature Immune-Related Genes in Patients With Hypertrophic Cardiomyopathy Based on Bioinformatics Analyses
por: Zheng, Xifeng, et al.
Publicado: (2021)

Modified GAN Augmentation Algorithms for the MRI-Classification of Myocardial Scar Tissue in Ischemic Cardiomyopathy
por: Sharma, Umesh C., et al.
Publicado: (2021)

Elevated α-hydroxybutyrate dehydrogenase is associated with in-hospital mortality in non-ischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2022)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2021)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Risk factors, clinical features, and outcomes of patients with hypertrophic cardiomyopathy complicated by ischemic stroke: A single-center retrospective study
por: Lu, Jian-Feng, et al.
Publicado: (2022)

Impact of late gadolinium enhancement extent, location, and pattern on ventricular tachycardia and major adverse cardiac events in patients with ischemic vs. non-ischemic cardiomyopathy
por: Tat, Emily, et al.
Publicado: (2022)

Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis
por: Song, Wenyu, et al.
Publicado: (2022)

Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy
por: Cittar, Marco, et al.
Publicado: (2021)

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2022)

Systematic analysis of myocardial immune progression in septic cardiomyopathy: Immune-related mechanisms in septic cardiomyopathy
por: Ma, Dunliang, et al.
Publicado: (2023)

Editorial: Metabolic Related Cardiomyopathy in Hyperglycemic Patients
por: Capuano, Annalisa, et al.
Publicado: (2022)

Multifocal ectopic purkinje-related premature contractions and related cardiomyopathy
por: Calloe, Kirstine, et al.
Publicado: (2023)

MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
por: Chen, Liuying, et al.
Publicado: (2021)

Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
por: Li, Zhitong, et al.
Publicado: (2022)

Identification of CALU and PALLD as Potential Biomarkers Associated With Immune Infiltration in Heart Failure
por: Liu, Xing, et al.
Publicado: (2021)

Identification of PTPN22 as a potential genetic biomarker for abdominal aortic aneurysm
por: Ruan, Peng, et al.
Publicado: (2022)

Development and validation of a predictive model of the impact of single nucleotide polymorphisms in the ICAM-1 gene on the risk of ischemic cardiomyopathy
por: Naman, Tuersunjiang, et al.
Publicado: (2022)

Outcomes of catheter ablation of ventricular tachycardia in non-ischemic idiopathic dilated cardiomyopathy: A systematic review and meta-analysis
por: Ammar, Ahmed, et al.
Publicado: (2022)

Implantable cardioverter defibrillator for primary prevention in patients with non-ischemic cardiomyopathy in the era of novel therapeutic agents- meta-analysis
por: Kolben, Yotam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ljrljd4t2tes6ouh7oj3q9d0oi